MedTrace Logo

To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-Face

NCT04437745 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 238

Last updated 2024-02-09

No results posted yet for this study

Summary

To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-Face

Conditions

  • Volume Defects in the Mid-face

Interventions

DEVICE

YVOIRE Y-Solution 720

Hyaluronic acid dermal filler

Sponsors & Collaborators

  • LG Chem

    lead INDUSTRY

Principal Investigators

  • Xiaojun Wang · Peking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-25
Primary Completion
2022-12-13
Completion
2023-11-08

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04437745 on ClinicalTrials.gov